Shire plc (SHPGY) Q2 2011 Earnings Call July 28, 2011 9:00 am ET Executives Graham Hetherington - Chief Financial Officer, Principal Accounting Officer and Director Angus Russell - Chief Executive Officer and Executive Director Sylvie Gregoire - Member of Management Committee and President of Human Genetic Therapies Business Eric Rojas - Director of Investor Relations - North America Michael Cola - President of Specialty Pharmaceuticals, Member of Senior Staff Committee and Member of Management Committee Analysts Florent Cespedes - Exane BNP Paribas William Tanner - Lazard Capital Markets LLC David Steinberg - Deutsche Bank AG Ken Cacciatore - Cowen and Company, LLC Brian Bourdot - Barclays Capital Peter Verdult - Morgan Stanley Brian White - Shore Capital Group plc Timothy Chiang - CRT Capital Group LLC David Buck - Buckingham Research Group, Inc. Justin Smith - MF Global UK Limited Keyur Parekh - Goldman Sachs Group Inc. Gary Nachman - Susquehanna Financial Group, LLLP PresentationOperator
Good day, ladies and gentlemen, and welcome to the Shire's 2011 Second Quarter Results Call, hosted by Angus Russell. My name is Phoebe, and I'm your event manager. [Operator Instructions] I'd like to advise all parties this conference is being recorded for replay purposes, and I'd like to hand over to Eric Rojas. Please go ahead, Eric. Eric Rojas Thanks, Phoebe. Good morning and good afternoon, everyone. Thank you for joining us today for Shire's Second Quarter 2011 Financial Results. By now, you should have all received our press release and should be viewing our presentation via our website on shire.com. If for some reason you have not received the press release or unable to access our website, please contact Souheil Salah in our U.K. Investor Relations department on +44 1256 894 160, and he'll be happy to assist you.